LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | GSK1059615 | 10.0 | uM | LJP5 | 1 | E01 | 72 | hr | 1476 | 609 | 3694 | 0.1649 | -0.3913 |
SK-BR-3 | GSK1059615 | 10.0 | uM | LJP5 | 2 | E01 | 72 | hr | 1476 | 863 | 3694 | 0.2336 | -0.2768 |
SK-BR-3 | GSK1059615 | 10.0 | uM | LJP5 | 3 | E01 | 72 | hr | 1476 | 801 | 3694 | 0.2168 | -0.3047 |
SK-BR-3 | GSK1059615 | 10.0 | uM | LJP6 | 1 | C01 | 72 | hr | 1476 | 810 | 3694 | 0.2193 | -0.3007 |
SK-BR-3 | GSK1059615 | 10.0 | uM | LJP6 | 2 | C01 | 72 | hr | 1476 | 955 | 3694 | 0.2585 | -0.2353 |
SK-BR-3 | GSK1059615 | 10.0 | uM | LJP6 | 3 | C01 | 72 | hr | 1476 | 765 | 3694 | 0.2071 | -0.3210 |
SK-BR-3 | GSK1904529A | 10.0 | uM | LJP6 | 1 | H19 | 72 | hr | 1476 | 3426 | 3694 | 0.9274 | 0.8791 |
SK-BR-3 | GSK1904529A | 10.0 | uM | LJP6 | 2 | H19 | 72 | hr | 1476 | 3737 | 3694 | 1.0116 | 1.0194 |
SK-BR-3 | GSK1904529A | 10.0 | uM | LJP6 | 3 | H19 | 72 | hr | 1476 | 3973 | 3694 | 1.0755 | 1.1258 |
SK-BR-3 | Omipalisib | 10.0 | uM | LJP6 | 1 | N01 | 72 | hr | 1476 | 702 | 3694 | 0.1900 | -0.3494 |
SK-BR-3 | Omipalisib | 10.0 | uM | LJP6 | 2 | N01 | 72 | hr | 1476 | 733 | 3694 | 0.1984 | -0.3354 |
SK-BR-3 | Omipalisib | 10.0 | uM | LJP6 | 3 | N01 | 72 | hr | 1476 | 862 | 3694 | 0.2334 | -0.2772 |
SK-BR-3 | GSK 690693 | 10.0 | uM | LJP5 | 1 | F19 | 72 | hr | 1476 | 3147 | 3694 | 0.8519 | 0.7533 |
SK-BR-3 | GSK 690693 | 10.0 | uM | LJP5 | 2 | F19 | 72 | hr | 1476 | 3095 | 3694 | 0.8378 | 0.7298 |
SK-BR-3 | GSK 690693 | 10.0 | uM | LJP5 | 3 | F19 | 72 | hr | 1476 | 3074 | 3694 | 0.8322 | 0.7204 |
SK-BR-3 | GW843682X | 10.0 | uM | LJP6 | 1 | B13 | 72 | hr | 1476 | 2361 | 3694 | 0.6391 | 0.3988 |
SK-BR-3 | GW843682X | 10.0 | uM | LJP6 | 2 | B13 | 72 | hr | 1476 | 2074 | 3694 | 0.5614 | 0.2694 |
SK-BR-3 | GW843682X | 10.0 | uM | LJP6 | 3 | B13 | 72 | hr | 1476 | 2185 | 3694 | 0.5915 | 0.3194 |
SK-BR-3 | HG-5-113-01 | 10.0 | uM | LJP5 | 1 | B07 | 72 | hr | 1476 | 1341 | 3694 | 0.3630 | -0.0612 |
SK-BR-3 | HG-5-113-01 | 10.0 | uM | LJP5 | 2 | B07 | 72 | hr | 1476 | 1377 | 3694 | 0.3728 | -0.0450 |
SK-BR-3 | HG-5-113-01 | 10.0 | uM | LJP5 | 3 | B07 | 72 | hr | 1476 | 1171 | 3694 | 0.3170 | -0.1379 |
SK-BR-3 | HG-5-88-01 | 10.0 | uM | LJP6 | 1 | A19 | 72 | hr | 1476 | 1758 | 3694 | 0.4759 | 0.1269 |
SK-BR-3 | HG-5-88-01 | 10.0 | uM | LJP6 | 2 | A19 | 72 | hr | 1476 | 1751 | 3694 | 0.4740 | 0.1237 |
SK-BR-3 | HG-5-88-01 | 10.0 | uM | LJP6 | 3 | A19 | 72 | hr | 1476 | 1579 | 3694 | 0.4274 | 0.0461 |
SK-BR-3 | Imatinib | 10.0 | uM | LJP6 | 1 | N13 | 72 | hr | 1476 | 3396 | 3694 | 0.9193 | 0.8656 |